Artificial Intelligence

Czech MedTech firm Stimvia builds a scientific and commercial 'dream team' to launch its non-invasive URIS® therapy for overactive bladder worldwide.

A new venture backed by Cerberus and Eos aims to fast-track U.S. energy storage with a novel model combining capital, tech, and insurance.

A new alliance between XRDNA and the University of Utah is building 'executable systems' that go beyond communication to actively coordinate the physical world.

Private equity firm Thurston Group launches Sensorium Clinical Research, a new network aiming to unify top trial sites and streamline medical innovation.

A new price feed for real-world assets like gold and Tesla promises continuous trading, challenging the 9-to-5 financial world and wooing institutions.

Merging onto Nasdaq, RTB Digital's 'Roundtable' platform aims to protect creators and upend the $200B media market with a bold 'Web4' vision.

A biotech firm says it has grown functional human sperm in a lab and created embryos, a huge leap that could change millions of lives and spark ethical debate.

Alibaba's earnings reveal a stark divide: soaring AI and cloud growth funded by a strategy that erased quarterly profits and torched cash flow.

A $25M payment from partner Chiesi catapults Protalix to a profitable quarter, funding a promising new gout therapy and a broader rare disease strategy.

Fourier and Intel reveal how modular, liquid-cooled systems are replacing components to power the next wave of AI, making deployment speed the ultimate weapon.

The German insurer posts a record €4.5B Q1 profit, leveraging AI and strong P&C results to navigate a volatile market and boost shareholder returns.

A new study reveals Efsubaglutide Alfa not only controls diabetes but may also improve the body's own insulin-producing cells, heralding a new era.

A new US-Taiwan partnership will equip unmanned boats with advanced AI, creating autonomous swarms to bolster the island's asymmetric defense strategy.

Disconnected tech systems create 'invisible leakage' in psychiatric practices, fueling burnout. A new approach aims to unify the operational chaos.

With a novel drug for schizophrenia and deep financial backing, LB Pharmaceuticals is advancing a promising new therapy for complex mental illnesses.

The cell-engineering firm posted a smaller-than-expected loss and announced a share buyback, signaling confidence despite a dip in core Q1 revenue.

After two rejections and a dramatic financial restructuring, Atara Biotherapeutics has a clear path to resubmit its key cancer therapy to the FDA.

AWE 2026 honors XR legends, unveils groundbreaking art and research, and champions a future where spatial AI empowers, not replaces, humanity.

UVeye's 'MRI for cars' just won a major AI award, proving its tech can spot tiny flaws human eyes miss, transforming vehicle safety from the factory to you.

The parent of Stop & Shop and Food Lion has hired a top data scientist. Here's how this move will reshape your shopping experience and the grocery industry.